Neuca S.A.

WAR:NEU Poland Medical Distribution
Market Cap
$792.41 Million
zł3.29 Billion PLN
Market Cap Rank
#13206 Global
#38 in Poland
Share Price
zł732.00
Change (1 day)
+0.97%
52-Week Range
zł649.00 - zł850.00
All Time High
zł953.88
About

NEUCA S.A. engages in the wholesale distribution of pharmaceuticals in Poland. It operates through Wholesale Distribution of Medicines, Manufacture of Pharmaceuticals, Medical Operator, Clinical Trials, and Insurance Activities segments. The company offers Rx, OTC drugs, dietary supplements, medical devices, dermocosmetics, hygiene products, personal protective equipment, as well as diagnostic an… Read more

Neuca S.A. (NEU) - Net Assets

Latest net assets as of September 2025: zł1.21 Billion PLN

Based on the latest financial reports, Neuca S.A. (NEU) has net assets worth zł1.21 Billion PLN as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (zł5.98 Billion) and total liabilities (zł4.76 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets zł1.21 Billion
% of Total Assets 20.28%
Annual Growth Rate 17.2%
5-Year Change 81.74%
10-Year Change 167.28%
Growth Volatility 23.54

Neuca S.A. - Net Assets Trend (2005–2024)

This chart illustrates how Neuca S.A.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Neuca S.A. (2005–2024)

The table below shows the annual net assets of Neuca S.A. from 2005 to 2024.

Year Net Assets Change
2024-12-31 zł1.41 Billion +33.54%
2023-12-31 zł1.06 Billion +13.61%
2022-12-31 zł930.54 Million +5.17%
2021-12-31 zł884.81 Million +13.90%
2020-12-31 zł776.80 Million +20.32%
2019-12-31 zł645.62 Million -1.42%
2018-12-31 zł654.89 Million +0.49%
2017-12-31 zł651.72 Million +10.92%
2016-12-31 zł587.58 Million +11.25%
2015-12-31 zł528.19 Million +13.00%
2014-12-31 zł467.42 Million +13.82%
2013-12-31 zł410.66 Million +20.00%
2012-12-31 zł342.21 Million +19.29%
2011-12-31 zł286.86 Million +17.87%
2010-12-31 zł243.37 Million +8.81%
2009-12-31 zł223.67 Million +27.62%
2008-12-31 zł175.26 Million +5.18%
2007-12-31 zł166.62 Million +112.37%
2006-12-31 zł78.46 Million +13.45%
2005-12-31 zł69.16 Million --

Equity Component Analysis

This analysis shows how different components contribute to Neuca S.A.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 16474.2% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings zł733.08 Million 64.35%
Common Stock zł4.49 Million 0.39%
Other Comprehensive Income zł55.26 Million 4.85%
Other Components zł346.31 Million 30.40%
Total Equity zł1.14 Billion 100.00%

Neuca S.A. Competitors by Market Cap

The table below lists competitors of Neuca S.A. ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Neuca S.A.'s equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 990,357,000 to 1,139,146,000, a change of 148,789,000 (15.0%).
  • Net income of 154,244,000 contributed positively to equity growth.
  • Dividend payments of 66,249,000 reduced retained earnings.
  • Share repurchases of 7,375,000 reduced equity.
  • New share issuances of 237,571,000 increased equity.
  • Other comprehensive income increased equity by 18,243,000.
  • Other factors decreased equity by 187,645,000.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income zł154.24 Million +13.54%
Dividends Paid zł66.25 Million -5.82%
Share Repurchases zł7.38 Million -0.65%
Share Issuances zł237.57 Million +20.86%
Other Comprehensive Income zł18.24 Million +1.6%
Other Changes zł-187.65 Million -16.47%
Total Change zł- 15.02%

Book Value vs Market Value Analysis

This analysis compares Neuca S.A.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 2.91x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 28.60x to 2.91x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2005-12-31 zł25.59 zł732.00 x
2006-12-31 zł29.04 zł732.00 x
2007-12-31 zł40.92 zł732.00 x
2008-12-31 zł41.35 zł732.00 x
2009-12-31 zł43.13 zł732.00 x
2010-12-31 zł47.60 zł732.00 x
2011-12-31 zł56.85 zł732.00 x
2012-12-31 zł68.53 zł732.00 x
2013-12-31 zł80.23 zł732.00 x
2014-12-31 zł91.21 zł732.00 x
2015-12-31 zł100.13 zł732.00 x
2016-12-31 zł114.15 zł732.00 x
2017-12-31 zł130.51 zł732.00 x
2018-12-31 zł128.65 zł732.00 x
2019-12-31 zł140.74 zł732.00 x
2020-12-31 zł172.79 zł732.00 x
2021-12-31 zł182.86 zł732.00 x
2022-12-31 zł192.39 zł732.00 x
2023-12-31 zł219.92 zł732.00 x
2024-12-31 zł251.19 zł732.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Neuca S.A. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 13.54%
  • The company shows good efficiency in utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 1.22%
  • • Asset Turnover: 2.29x
  • • Equity Multiplier: 4.84x
  • Recent ROE (13.54%) is below the historical average (16.47%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2005 15.63% 0.76% 3.81x 5.37x zł3.89 Million
2006 14.37% 0.66% 3.13x 6.93x zł3.43 Million
2007 10.18% 0.50% 2.88x 7.11x zł291.60K
2008 8.36% 0.36% 2.94x 8.00x zł-2.77 Million
2009 17.79% 0.64% 2.80x 9.93x zł15.91 Million
2010 16.10% 0.61% 2.95x 8.91x zł14.24 Million
2011 19.05% 0.83% 3.24x 7.05x zł25.27 Million
2012 19.64% 1.16% 3.04x 5.57x zł32.40 Million
2013 21.03% 1.47% 3.02x 4.73x zł44.77 Million
2014 20.32% 1.42% 2.56x 5.61x zł47.27 Million
2015 19.59% 1.46% 2.59x 5.19x zł49.58 Million
2016 19.30% 1.58% 2.63x 4.65x zł53.85 Million
2017 14.64% 1.26% 2.57x 4.51x zł29.94 Million
2018 15.04% 1.27% 2.49x 4.77x zł32.91 Million
2019 18.26% 1.42% 2.43x 5.30x zł53.23 Million
2020 18.51% 1.53% 2.57x 4.71x zł65.17 Million
2021 17.78% 1.53% 2.40x 4.86x zł65.93 Million
2022 15.59% 1.22% 2.32x 5.50x zł49.21 Million
2023 14.77% 1.24% 2.28x 5.23x zł47.23 Million
2024 13.54% 1.22% 2.29x 4.84x zł40.33 Million

Industry Comparison

This section compares Neuca S.A.'s net assets metrics with peer companies in the Medical Distribution industry.

Industry Context

  • Industry: Medical Distribution
  • Average net assets among peers: $491,223,000
  • Average return on equity (ROE) among peers: 10.31%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Neuca S.A. (NEU) zł1.21 Billion 15.63% 3.93x $279.51 Million
Sopharma AD (SPH) $491.22 Million 10.31% 0.75x $244.08 Million